131 related articles for article (PubMed ID: 2719531)
1. [Determination of N-acetylneuraminic acid for the differential diagnosis of cystic ovarian tumors].
Donat H; Bernstein L; Schenk H; Erbstösser E; Rosé A
Arch Geschwulstforsch; 1989; 59(2):113-20. PubMed ID: 2719531
[TBL] [Abstract][Full Text] [Related]
2. [Sialic acid concentrations in blood samples as well as in cyst and peritoneal fluid in patients with ovarian cysts and cystic ovarian tumors].
Strache RR; Büttner HH; Göcze PM; Briese V
Zentralbl Gynakol; 1990; 112(23):1445-53. PubMed ID: 2291368
[TBL] [Abstract][Full Text] [Related]
3. [Differential diagnosis of cystic ovarian tumors by determination of estradiol in cystic aspirate].
Ammann M; Hänggi W; Baumann U; Keller PJ
Geburtshilfe Frauenheilkd; 1991 Jun; 51(6):481-3. PubMed ID: 1889731
[TBL] [Abstract][Full Text] [Related]
4. [CA-125 values in fluid and serum in females with cystic ovarian tumors].
Sautter T; Mickan H
Gynakol Rundsch; 1990; 30 Suppl 1():208-9. PubMed ID: 2079272
[No Abstract] [Full Text] [Related]
5. [CEA determination in aspired fluid of cystic ovarian tumors and ovarian cysts and in ascites and serum samples of patients with ovarian tumors].
Kunze M; Büttner HH; Strache RR; Voss P; Briese V; Schrodt U
Zentralbl Gynakol; 1988; 110(16):1006-12. PubMed ID: 3188713
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823
[TBL] [Abstract][Full Text] [Related]
7. [Value of N-acetylneuraminic acid (NANA) in the serum of patients with gynecologic cancers].
Schrempel A; Kürschner M
Zentralbl Gynakol; 1985; 107(3):175-8. PubMed ID: 3984572
[TBL] [Abstract][Full Text] [Related]
8. The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?
Ivarsson K; Runesson E; Sundfeldt K; Haeger M; Hedin L; Janson PO; Brännström M
Gynecol Oncol; 1998 Dec; 71(3):420-3. PubMed ID: 9887242
[TBL] [Abstract][Full Text] [Related]
9. Comparison of biochemical markers between benign and malignant ovarian cysts.
Knight JA; Wu JT; Miya T; Knight DP
Clin Physiol Biochem; 1986; 4(2):130-5. PubMed ID: 3516514
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
Suzuki M; Tamura N; Kobayashi H; Ohwada M; Terao T; Sato I
Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350
[TBL] [Abstract][Full Text] [Related]
11. Significance of some tumor markers in differential diagnosis of ovarian tumor.
Zakrzewska I; Borawska R; Poznański J; Maćkowiak B
Rocz Akad Med Bialymst; 1999; 44():235-43. PubMed ID: 10697438
[TBL] [Abstract][Full Text] [Related]
12. [Placental protein 12 (PP 12) in cyst and peritoneal fluids and serum samples of patients with ovarian cysts and cystic ovarian tumors].
Strache RR; Göcze PM; Szábo DG; Büttner HH; Briese V; Kunze M; Csaba IF; Röpcke G
Zentralbl Gynakol; 1989; 111(11):749-54. PubMed ID: 2781888
[TBL] [Abstract][Full Text] [Related]
13. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group.
Timmerman D; Testa AC; Bourne T; Ferrazzi E; Ameye L; Konstantinovic ML; Van Calster B; Collins WP; Vergote I; Van Huffel S; Valentin L;
J Clin Oncol; 2005 Dec; 23(34):8794-801. PubMed ID: 16314639
[TBL] [Abstract][Full Text] [Related]
14. Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts.
Sundfeldt K; Ivarsson K; Rask K; Haeger M; Hedin L; Brännström M
Anticancer Res; 2001; 21(1A):65-70. PubMed ID: 11299791
[TBL] [Abstract][Full Text] [Related]
15. [Determination of carcinoembryonic antigen in puncture fluid of cystic ovarian tumors and ovarian cysts].
Büttner HH; Kunze M; Voss P
Gynakol Rundsch; 1988; 28 Suppl 2():179-80. PubMed ID: 3234915
[No Abstract] [Full Text] [Related]
16. Aspiration cytology and E2 content in ovarian tumors.
Geier GR; Strecker JR
Acta Cytol; 1981; 25(4):400-6. PubMed ID: 6945006
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted echo-planar MR imaging and ADC mapping in the differential diagnosis of ovarian cystic masses: usefulness of detecting keratinoid substances in mature cystic teratomas.
Nakayama T; Yoshimitsu K; Irie H; Aibe H; Tajima T; Nishie A; Asayama Y; Matake K; Kakihara D; Matsuura S; Nakano H; Honda H
J Magn Reson Imaging; 2005 Aug; 22(2):271-8. PubMed ID: 16028258
[TBL] [Abstract][Full Text] [Related]
18. [The diagnostic value of the assay of lactate dehydrogenese combined with other tumor markers in ovarian cancer].
Tang BJ; Li L; Xu J
Zhonghua Fu Chan Ke Za Zhi; 1994 Jun; 29(6):336-9, 381. PubMed ID: 8001406
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder.
Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
Gynecol Oncol; 2006 Sep; 102(3):542-5. PubMed ID: 16510173
[TBL] [Abstract][Full Text] [Related]
20. Determination of sialic acids in the serum of cancer patients by capillary electrophoresis.
Dong X; Xu X; Han F; Ping X; Yuang X; Lin B
Electrophoresis; 2001 Jul; 22(11):2231-5. PubMed ID: 11504057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
